Senhwa Biosciences, Inc. (TPEX:6492)

Senhwa Biosciences Revenue

Senhwa Biosciences had revenue of 240.00K TWD in the quarter ending March 31, 2026, a decrease of -4.00%. This brings the company's revenue in the last twelve months to 1.06M, up 6.00% year-over-year. In the year 2025, Senhwa Biosciences had annual revenue of 1.07M with 7.00% growth.

• Revenue (ttm): 1.06M
• Revenue Growth: +6.00%
• P/S Ratio: 3,811.55
• Revenue / Employee: n/a
• Employees: n/a
• Market Cap: 4.04B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	1.07M	70.00K	7.00%
Dec 31, 2024	1.00M	-	-
Dec 31, 2023	1.00M	-	-
Dec 31, 2022	1.00M	450.00K	81.82%
Dec 31, 2021	550.00K	-67.00K	-10.86%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

May 25, 2026

Data Sources Report a data error